Physician

James K. Aikins, MD

According to 2025 Medicare claims, James Aikins, MD (NPI: 1346337839) practices gynecologist/oncologist in the Lakewood-New Brunswick, NJ market, with the plurality of this provider's patient population coming from Middlesex, NJ. This provider's primary affiliated billing organization is RUTGERS HEALTH-RWJ SCLERODERMA PROGRAM (NPI: 1487688495; TIN: 223371727) and primary practice location at 08901-1928. Aikins is affiliated with the Vytalize Health 9 ACO LLC (ACO ID: D0313), participating under the REACH model.

Aikins' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 66 traditional Medicare patients, billed 165 HCPCS/CPT codes, and received $19,736 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 77 prescription claims across 33 beneficiaries totaling $139,417 in drug costs, led by Estradiol (Estradiol). Open Payments data shows 4 records totaling $122. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing started with an early spike, then settled into a lower baseline, moving from $88,076 to $19,736. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $32,014 and ending at $139,417. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$59K$117K2015 Medicare payment: $88,076 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $117,198 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $85,838 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $74,522 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $75,733 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $55,606 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $15,225 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $21,777 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $24,420 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $19,736 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015300694$88,076
2016323792$117,198
2017252646$85,838
2018272556$74,522
2019216503$75,733
2020183423$55,606
20213990$15,225
202274159$21,777
202382186$24,420
202466165$19,736

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$197K$394K2015 Drug cost: $32,014 (USD; Tot_Drug_Cst)2016 Drug cost: $12,643 (USD; Tot_Drug_Cst)2017 Drug cost: $8,959 (USD; Tot_Drug_Cst)2018 Drug cost: $27,941 (USD; Tot_Drug_Cst)2019 Drug cost: $262,663 (USD; Tot_Drug_Cst)2020 Drug cost: $394,315 (USD; Tot_Drug_Cst)2021 Drug cost: $119,104 (USD; Tot_Drug_Cst)2022 Drug cost: $105,988 (USD; Tot_Drug_Cst)2023 Drug cost: $212,001 (USD; Tot_Drug_Cst)2024 Drug cost: $139,417 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201573307$32,014
201668272$12,643
201763226$8,959
201850167$27,941
201960195$262,663
202071306$394,315
20213476$119,104
20223491$105,988
20234395$212,001
20243377$139,417

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99215Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more1118$110
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more1315$82
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more4180$65

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
EstradiolEstradiol16542$341

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.4$122GlaxoSmithKline, LLC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for James K. Aikins, MD?

Tedicare shows public-source Medicare data for James K. Aikins, MD (NPI 1346337839), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does James K. Aikins, MD have ACO affiliation data?

James K. Aikins, MD is shown with ACO affiliation data for Vytalize Health 9 ACO LLC (REACH, ACO ID D0313).

What billing organization is linked to James K. Aikins, MD?

James K. Aikins, MD is linked to RUTGERS HEALTH-RWJ SCLERODERMA PROGRAM (billing NPI 1487688495) in the available physician profile data.

Does James K. Aikins, MD have Open Payments data?

James K. Aikins, MD has 4 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.